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g.2013.0Abstract Background: Type 1 diabetes is one of the most common chronic childhood illnesses.
Interplay between genetic susceptibility and environmental factors is thought to provide the funda-
mental element for the disease. Apart from the Major Histocompatibility locus which is the main
contributor to risk susceptibility, more than 40 loci are recognized. One among these is the
CTLA-4, however data from the literature are controversial. The aim of our study was to investi-
gate the role of CTLA4 49 A/G as a risk susceptibility factor for the development of type 1 diabetes
in a cohort of Egyptian families.
Subjects and methods: This is a case control study including 88 Egyptian families with one or
more index cases (<18 years). The control group comprised 369 healthy unrelated subjects with
no family history of diabetes or autoimmune disease.
Using PCR-RFLP methodology, CTLA4 49 A/G was analyzed in 738 samples representing 88
families (88 patients, 125 siblings and 156 parents) and 369 control.onal Cancer Institute, Cairo University, Fom El-Khalig Square, Kasr El-Ainin St., 11796 Cairo, Egypt.
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26 A.M. Kamel et al.Results: The age of onset was 6 days-12.5 years with a mean of 5.3 ± 3.6 and a median of
5 years. The mode of presentation was classic symptoms in 51 and diabetic ketoacidosis in 37 cases.
Twenty-two cases had a history of viral infection or exanthematous disease and four had associated
autoimmune diseases. No signiﬁcant differences were encountered between the different groups
with regard to CTLA4 +49 A/G genotype or allele frequencies. Neither was there a relation
between the various genotypes and age of onset or the mode of presentation.
Conclusions: CTLA4 49 A/G polymorphism was not recognized as a risk susceptibility factor in
our cohort. This may be attributed to the low co-incidence of autoimmune diseases. Up to our best
knowledge, this is the ﬁrst study involving families. We recommend that all studies performed on
risk susceptibility to type 1 diabetes should include proper investigation for other autoimmune dis-
eases to exclude their confounding effect on data analysis.
 2014 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
Type 1 diabetes is one of the most common chronic child-
hood illnesses; its incidence is characterized by extensive dif-
ferences between populations [1–3]. In Egypt prevalence rate
varying between 0.7 and 1.9 was reported [4–6]. Type 1 dia-
betes develops in individuals who are genetically susceptible;
interplay between genetic susceptibility and environmental
factors is thought to provide the fundamental element for
the disease [7].
Alleles or genetic variants associated with type 1 diabetes
provide either susceptibility to or protection from the disease
within a given environmental background [8]. The genetic ma-
keup with the balance between susceptibility and protection al-
leles determines the age of onset of type 1 diabetes [7]. The risk
for siblings of affected individuals is approximately 15 times as
great as the risk in general population [9]. The offspring of a
mother with type 1 diabetes mellitus is 4–10 times while that
for offspring of a diabetic father is 15–22 times [10–12].The
gender bias in transmission rate has not been fully explained
[13–15]. The major genetic determinant of susceptibility to type
1 diabetes lies within the major histocompatibility complex
(IDDM1) [16,17]. However, within diabetic families HLA
identical siblings, though at a higher risk, do not always devel-
op diabetes. This brought into the focus of interest other pos-
sible genetic loci and currently more than 40 DDM loci are
recognized [18]. Among these is the cytotoxic T lymphocyte
antigen-4 (CTLA-4) known as insulin-dependent diabetes mel-
litus 12 (IDDM 12). An A/G polymorphism in the ﬁrst exon of
CTLA-4 results in an amino acid change (Thr/Ala). The pres-
ence of an alanine at codon 17 of CTLA-4 has been associated
with susceptibility to type 1 diabetes, autoimmune thyroiditis,
systemic lupus erythematosis, celiac disease and biliary cirrho-
sis [19–21]. However there is a marked controversy about its
effect on type 1 diabetes. On one side the effect of IDDM12
is claimed to be independent of other genetic markers of type
1 diabetes [22]. On the other side it is claimed to be weak or
even questionable [23]. Ethnic heterogeneity has been reported
with strong effects in some populations and weak transmission
in others [22].
In view of the possible ethnic variations and the different
environmental contributions in different societies, it is essen-
tial to study the main loci contributing to the susceptibility
to or protection from type 1 diabetes in each community; re-
sults obtained from studying one population cannot be
extrapolated to others.Studies performed in Egypt on genetic background of type
1 diabetes, including ongoing studies of the research team,
have so far addressed mainly the contribution of the HLA re-
gion. Recently two Egyptian studies have addressed the role of
IDDM12 in risk susceptibility to type 1 diabetes; both were
case-control studies not involving families.
2. Subjects and methods
The work is carried out in accordance with The Code of Ethics
of the World Medical Association (Declaration of Helsinki)
for experiments involving humans. The protocol was revised
and approved by the Institutional Review Board (IRB) of
the National Cancer Institute, Cairo University. A written in-
formed consent was obtained from all participants or their
parents.
2.1. Subjects
The study cohort included 88 Egyptian families with one or
more index diabetic children or adolescents who are attending
outpatient clinic in the Diabetes Endocrinology and Metabo-
lism Pediatrics Unit (DEMPU), at Cairo University Children
Hospital. CTLA-4 was analyzed in 369 samples representing
88 families (88 patients, 125 siblings and 156 parents) and
369 controls. Seven siblings, belonging to 6 families, are dia-
betic and were excluded from the analysis; only the 118 non-
diabetic siblings were analyzed.
Patient’s age at the time of the study ranged from 1 to
18 years with a mean of 8.6 ± 4 and a median of 9 years.
Thirty-ﬁve of our patients were males and 53 were females.
The controls were chosen from blood bank donors. They were
healthy unrelated subjects with no family history of diabetes or
other autoimmune diseases. The choice of adults was to guar-
antee that they would not develop juvenile diabetes and to
avoid ethical issues of using healthy children as controls.
2.2. DNA analysis and polymerase chain reaction-restriction
fragment length polymorphism (PCR-RFLP) testing for
CTLA-4 +49 A/G
Genomic DNA was extracted from EDTA peripheral blood
samples using the salting out technique [24]. Identiﬁcation of
the loci was performed based on the PCR-RFLP protocol
[25]. Oligonucleotide primers were synthesized (Pharmacia bio-
tech). The ampliﬁcation of the CTLA-4 gene was performed in
Figure 1 CTLA4–49 A/G genotypes after BbvI digestion. Lane
1: 100 bp Ladder. Lanes 2, 4 and 5: Heterozygous: AG: 327 bp,
244 bp and 84 bp. Lane 3: Wild type: AA: 327 bp. Lanes 6:
Homozygous: GG: 244 bp and 84 bp.
Lack of association of CTLA-4 +49 A/G polymorphism with predisposition to type 1 diabetes 27a 25 ll PCR reaction containing 100 ng of genomic DNA,
25 pmol of each primer (forward primer 50-
CCACGGCTTCCTTTCTCGTA-30 and a reverse primer 50-
AGTCTCACTCACCTTTGCAG-30), 100 lM each dNTP,
1.5 mM MgCl2 and 1.2 U Taq polymerase (Promega, Madi-
son). PCR conditions consisted of initial denaturation at
95 C for 2 min, followed by 40 cycles at 94 C for 30 s,
50 C for 45 s and 72 C for 30 s and a ﬁnal extension step
at 72 C for 10 min. This results in a fragment of 327 bp.
Digestion of the PCR product was performed in a 20 ll mix
containing 10 ll of the PCR product, 10 U BbvI (Fermentas)
and 1 X buffer. The mix was incubated at 65 C for 15 min. Di-
gested products were separated on 2% agarose. This resulted
in no digestion with a 327 bp single band in the wild type
(AA) and two bands of 244 bp and 83 bp with G allele
(Fig. 1) compared to 100 base pair ladder (Thermo-
Fermentas).
2.3. Statistical analysis
SPSS version 17.0 was used for data management. Proportions
were compared using the Chi square test and Fisher exact.Table 1 Allele Frequency of CTLA4 49 A > G in type 1 diabetes
Group No CTLA4 Genotype
Wild AA Heter
Type 1 Diabetics 88 47
53.4%
36
40.9%
Non-diabetic siblings 118* 66
55.9%
40
33.9%
Parents 156 74
47.4%
68
43.6%
Control 369 199
53.9%
150
40.7%
* Seven more siblings were analyzed and excluded as they are diabetics.Odds ratio of genotype(s) was calculated with 95% conﬁdence
interval. Parametric and non parametric tests compared the
means of two or more than two independent groups (t test
and ANOVA). P value was always two tailed and considered
signiﬁcant at 0.05 level.3. Results
The age of onset ranged from 6 days to 12.5 years with a mean
of 5.3 ± 3.6 and a median of 5 years. The age of onset was
<1 year in 17 cases; 8 of them <6 months. The mode of pre-
sentation was classic symptoms in 51 and diabetic ketoacidosis
(DKA) in 37 cases. Twenty-two cases had a history of viral
infection or exanthematous disease before the onset of diabetes
and 4 had associated autoimmune diseases namely, Hashimot-
o’s thyroiditis, rheumatoid arthritis, rheumatic heart disease
and Crohn’s disease. Early introduction of cow’s milk or cere-
als was reported in 45 cases while exclusive breast feeding in
the ﬁrst 6 months was adopted for the others.
The CTLA-4 +49 A/G genotype and allele frequency
among the different groups are presented in Table 1 and
Fig. 1. Distribution of CTLA-4 genotypes and alleles in pa-
tients compared to control did not show any signiﬁcance
(Table 2). Comparing patients with controls, non diabetic sib-
lings and parents regarding AA versus AG+ GG also did not
show signiﬁcance (p= 0.60, 0.49 and 0.68 respectively). Nei-
ther was there a relation between the various genotypes and
age of onset nor the mode of presentation.4. Discussion
At present, the development of type 1 diabetes mellitus is a life
sentence to a difﬁcult therapeutic regimen that is only partially
effective in preventing acute and chronic complications of the
disease. Knowledge of the genetics of type 1 diabetesmellitus in
our community would allow better disease deﬁnition and im-
proved ability to identify individuals at risk of diabetes and
its associated disorders. In the current work, we studied 88
families with one or more children with type 1 diabetes. Our
study showed female predominance which comes in agreement
with the assumption that female predominance is encountered
in regions with low incidence mainly populations of non-Euro-
pean origin [26]. This was denied in a more recent study that
reported equal incidence in both genders with female predom-
inance only in autoimmune diseases [27]. This explanation isFamilies.
G Allele frequency
o AG Homo GG No. %
5
5.7%
46/176 26.1
12 10.2% 67/250 26.8
14
9.0%
96/312 32.8
20
5.4%
190/738 25.7
Table 2 Distribution of CTLA449 A/G in type 1 diabetes as compared to control.
Allele/Genotype Patients (88) Control (369) OR 95% CI P value
A 130 (73.9) 548 (74.3) 1.03 0.65–1.51 0.93
G 46 (26.1) 190 (25.7) 1.02 0.7–1.48 0.92
AA 47 (53.4) 199 (53.9) 1.03 0.67–1.7 0.96
AG 36 (40.9) 150 (40.7) 1.02 0.63–1.65 0.95
GG 5 (5.7) 20 (5.4) 1.06 0.38–2.97 1.0
AG+ GG 41 (46.6) 170 (46.1) 1.02 0.64–1.63 0.93
28 A.M. Kamel et al.not applicable in our case as only four of our patients have a
concomitant autoimmune disease.
In our study, early introduction of cow’s milk or cereals
was not a contributing factor to the development of type 1 dia-
betes. This is in agreement with one study from Finland [28]
and another from Iran [29]. In the former study, it was even
claimed that early introduction of cow’s milk reduced the risk
of development of type 1 diabetes before the age of 8 years; an
effect that was abolished by the age of 15. In the latter, it was
claimed that the total duration of cow’s milk feeding rather
than its early introduction would increase the risk of type 1 dia-
betes while longer duration of breast feeding is associated with
protection. No effect of early introduction of cow’s milk or
cereals was also reported in Saudi Arabia [30]. In our study,
history of viral infection or exanthematous disease was not
associated with increased risk of type 1 diabetes. This is in
agreement with Cherian et al. [30] who studied the impact of
environmental factors on risk susceptibility to type 1 diabetes
in the Eastern Province of Saudi Arabia. However, irregular
vaccination and infection in the prior 6 months were reported
as a trigger for the onset of type 1 diabetes [31].
Genotypes of CTLA-4 +49 A/G were in Hardy Weinberg
equilibrium in patients, siblings, parents and control subjects
(p> 0.05). In our studied cohort CTLA-4 +49 A/G did not
have any impact on risk susceptibility to type 1 diabetes. Nei-
ther has it shown an impact on the age of onset of the disease.
Interest in CTLA-4 was raised because of its role in T cell sig-
naling as a negative regulator of T-cell activation and effector
function [32,33]. The association of CTLA-4 polymorphism
with type 1 diabetes was ﬁrst reported in Italian subjects [34]
and conﬁrmed thereafter in several other studies [20,35–37].
However, the association was claimed to be Caucasian selec-
tive [38,39] as it was not detected in Korean [40], Portugese
[41], [42] Chelian [43] or Azrbaijanian [44] populations. Our
data are different from studies performed in populations from
neighboring countries namely Lebanon, [45], Tunisia [46] and
Iran [47]; a higher frequency of the G allele or GG genotype in
type 1 diabetesmellitus in children was reported in all. Analysis
of 24 CTLA-4 SNPs in the Type I Diabetes Genetics Consor-
tium families did not include CTLA-4 49 A/G SNP [48].
Most important is that our ﬁndings are different from two
case-control Egyptian studies [49,50]. They demonstrated that
the G allele is overrepresented in type 1 diabetes patients com-
pared to controls. Explanation of this controversy may be ex-
tracted from the study of Ikegami et al. [51]. These authors
suggested that CTLA-4 is signiﬁcantly associated with autoim-
mune thyroid disease (AITD) but not with type 1 diabetes; be-
cause of the strong association of AITD and type 1 diabetes,
the association of CTLA-4 polymorphism with type 1 diabetes
may be secondary to its association with AITD. To verify theirtheory, they divided their type 1 diabetes mellitus patients into
two groups, those with and those without AITD. CTLA-4
polymorphism was found to be signiﬁcantly associated with
the type 1 diabetes with, but not with the group of type 1 dia-
betes without AITD indicating that the association is mainly
with AITD not type 1 diabetes. Analyzing the Egyptian studies
in view of these data, AITD was present in only four of our
patients; the other two Egyptian studies did not comment on
the associated autoimmune diseases in their cohorts.
In conclusion, CTLA-4 +49 A/G polymorphism was not
recognized as a risk susceptibility factor in our cohort of Egyp-
tian type 1 diabetes families. We recommend that all studies
performed on risk susceptibility to type 1 diabetes should in-
clude proper investigation for other autoimmune diseases to
exclude their confounding effect on data analysis.
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